Encorafenib (trade name Braftovi) is a drug for the treatment of certain melanomas. it is a kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. Reference standards of Encorafenib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Encorafenib
Catalogue No.:PA 05 1940000
CAS :
Molecular Formula : C22H27ClFN7O4S
Molecular Weight : 540.01
Encorafenib R-Isomer
Catalogue No.:PA 05 1941000
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....